Chengying Huang

发表

Abstract. To improve the treatment strategy of immune‐check‐ point inhibitors for non‐small cell lung cancer (NSCLC), a comprehensive analysis of programmed death‐ligand (PD‐L)1 and PD‐L2 expression is clinically important. The expression of PD‐L1 and PD‐L2 on both tumor cells (TCs)

H. Date, M. Fujita, Ryota Sumitomo, 2022 .

An integrated analysis of C5AR2 related to malignant properties and immune infiltration of gliomas

Zhicheng Hu, S. Qu, O. Qiu, 2022, Cancer innovation.

Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells

Zhicheng Hu, S. Qu, Chengying Huang, 2022, MedComm.

Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis.

Nan Liu, Xiaolin Lin, Chengying Huang, 2021, Gynecologic oncology.

Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance

Xiaolin Lin, Chengying Huang, N. Liu, 2019, British Journal of Cancer.

Roles of Tenascin-XB in the Glioma Immune Microenvironment

S. Qu, O. Qiu, Chengying Huang, 2022, BIO Integration.

OLFML3, as a potential predictor of prognosis and therapeutic target for glioma, is closely related to immune cell infiltration

Hao Zheng, Guo-zhong Yi, S. Qi, 2023, VIEW.

The PODNL1/AKT/β-catenin Signaling Axis Mediates Glioma Progression and Sensitivity to Temozolomide

S. Qu, Zhicheng Hu, Chengying Huang, 2023, Fundamental Research.

Targeting the ferroptosis crosstalk: novel alternative strategies for the treatment of major depressive disorder

Guo-zhong Yi, Chengying Huang, Guang-long Huang, 2023, General Psychiatry.